Serum Free Fatty Acid Metabolite Biomarkers of Lung Cancer

Completed

Conditions studied: Lung Cancer, Biomarkers, Fatty Acids

In brief

This study aims to evaluate the performance of serum free fatty acids as biomarkers for the identification of lung cancer.

Key facts

Study ID

NCT01692951

Run by

The Cleveland Clinic

People needed

220

Starts

2012-08-01

Expected to finish

2014-09-01

Last updated by the study team

2017-06-20

Who can join

Age: 40 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age from 40 to 80
• Lung adenocarcinoma with pathological diagnosis
• Lung squamous cell carcinoma with pathological diagnosis
• Control patients should have at least one of the following criteria: (1) current or ex-smoker with at least a 10 pack-year history, (2) a first-degree relative with a history of lung cancer, or (3) a clinical diagnosis of COPD.

You may not qualify if…

• Lung cancer patient without serum sample before the initiation of treatment

Where it is running

• Cleveland Clinic — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.